Making a case for mitochondria in hypertrophic cardiomyopathy
Related Experiment Video
Updated: Jun 19, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Pankaj Prasun1, Utkarsh Kohli1
1Department of Pediatrics, West Virginia University Medicine, Morgantown, WV 26506, USA.
Insights
Hypertrophic cardiomyopathy (HCM) is linked to mitochondrial disease. Sequencing the mitochondrial genome is crucial for diagnosing HCM, especially in genotype-negative cases, and may guide new therapies.
Area of Science:
- Genetics
- Cardiology
- Mitochondrial Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is a significant manifestation of inherited mitochondrial disease.
- Current genetic testing panels for HCM often exclude mitochondrial genome sequencing.
- Mitochondrial dysfunction is implicated in HCM pathogenesis, irrespective of nuclear gene panel results.
Observation:
- Mitochondrial DNA variations can modify disease presentation in individuals with known HCM genotypes.
- In individuals negative for known HCM genetic causes (genotype-negative), mitochondrial dysfunction may be the primary driver of the disease.
- A recent study linked mitochondrial dysfunction to septal hypertrophy in genotype-negative HCM patients.
Findings:
- Mitochondrial genome sequencing should be integrated into the genetic evaluation of HCM.
- Mitochondrial dysfunction is a key factor in HCM, even when standard genetic tests are negative.
- Septal hypertrophy in genotype-negative HCM is associated with mitochondrial dysfunction.
Implications:
- Including mitochondrial sequencing could improve diagnostic yield for HCM.
- Targeted therapies aimed at mitochondrial dysfunction may benefit HCM patients, particularly those who are genotype-negative.
- Understanding the role of mitochondrial DNA in HCM can lead to personalized treatment strategies.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a well-known manifestation of inherited mitochondrial disease. Still, currently available gene panels do not include mitochondrial genome sequencing. Mitochondrial dysfunction plays a very important role in the pathogenesis of HCM, whether tested positive or negative by the currently available gene panels for HCM. Mitochondrial DNA variations may act as modifiers of disease manifestation in genotype-positive individuals. In genotype-negative individuals, it may be the primary driver of pathogenesis. A recent study has demonstrated that mitochondrial dysfunction is correlated with septal hypertrophy in genotype-negative HCM, which can be amenable to mitochondria-targeted therapy. It is important to consider mitochondrial genome sequencing as part of the genetic evaluation of HCM.
Related Concept Videos
Mitochondria
Pathophysiology of Heart Failure
The Inner Mitochondrial Membrane
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

